Extracorporeal life support allows lung transplant in anti-MDA5+ rapidly progressive interstitial lung disease. Bay P, Pineton de Chambrun M, Roux A, Bunel V, et al. Eur Respir J 2022;59.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bay P, Pineton de Chambrun M, Roux A, Bunel V, et al. Extracorporeal life support allows lung transplant in anti-MDA5+ rapidly progressive interstitial lung disease. Eur Respir J 2022;59.
PMID: 35236721